A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India

Exclusion Criteria

• •Previous participation in this study. Participation is defined as having given informed consent in this study
• •Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• •Patient with a history of thromboembolism
• •Patient with a history of bleeding disorders
• •Patient with a history of or ongoing disseminated intravascular coagulation (DIC); haemolysis, elevated liver enzymes, low platelet count (HELLP) syndrome, thrombotic thrombocytopenic purpura (TTP), pre-eclampsia or other severe complication of childbirth apart from severe PPH
• •Have undergone invasive obstetric procedures for the ongoing haemorrhage prior to trial enrolment (uterine balloon tamponade and external aortic compression not included)
• •Any chronic disorder or severe disease which, in the opinion of the Investigator, might jeopardise patient's safety or compliance with the protocol
• •Participation (i.e., signed informed consent) in any other interventional clinical study prior to screening in the current study